An exploratory comparative case series of calcitonin gene-related peptide monoclonal antibodies in patients with migraine with rosacea

被引：2
|
作者：
Sia, Twan [1 ]
Webb, Taylor [1 ]
Li, Shufeng [1 ,2 ]
Moskatel, Leon S. [3 ]
Chang, Anne Lynn S. [1 ]
机构：
[1] Stanford Univ, Sch Med, Dept Dermatol, Redwood City, CA 94063 USA
[2] Stanford Univ, Sch Med, Dept Urol, Acad Med Ctr, Palo Alto, CA USA
[3] Stanford Hlth Care, Dept Neurol & Neurol Sci, Stanford, CA USA
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2023年 / 189卷 / 06期
关键词：
D O I：
10.1093/bjd/ljad277
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
[No abstract available]
引用
收藏
页码：776 / 778
页数：3
相关论文
共 50 条
  • [1] Use of calcitonin gene-related peptide monoclonal antibodies in patients with rosacea: An exploratory, comparative case series
    Sia, T.
    Webb, T.
    Li, S.
    Moskatel, L.
    Chang, A. L.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (05) : S80 - S80
  • [2] Calcitonin gene-related peptide (CGRP) monoclonal antibodies for migraine
    Giffin, Nicola J.
    PRACTICAL NEUROLOGY, 2023, 23 (03) : 200 - +
  • [3] Monoclonal Antibodies for Migraine: Preventing Calcitonin Gene-Related Peptide Activity
    Marcelo E. Bigal
    Sarah Walter
    CNS Drugs, 2014, 28 : 389 - 399
  • [4] Monoclonal Antibodies for Migraine: Preventing Calcitonin Gene-Related Peptide Activity
    Bigal, Marcelo E.
    Walter, Sarah
    CNS DRUGS, 2014, 28 (05) : 389 - 399
  • [5] Switching of monoclonal antibodies against calcitonin gene-related peptide in chronic migraine in clinical practice: a case series
    Del Pilar Briceno-Casado, Maria
    David Gil-Sierra, Manuel
    De-la-Calle-Riaguas, Beatriz
    EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2023, 30 (04)
  • [6] Case series on monoclonal antibodies targeting calcitonin gene-related peptide in migraine patients during pregnancy: Enhancing safety data
    Elosua-Bayes, Iker
    Alpuente, Alicia
    Melgarejo, Laura
    Caronna, Edoardo
    Torres-Ferrus, Marta
    Pozo-Rosich, Patricia
    CEPHALALGIA, 2024, 44 (09)
  • [7] Adherence and persistence associated with calcitonin gene-related peptide monoclonal antibodies compared to non-calcitonin gene-related peptide monoclonal antibodies treatments for prevention of migraine
    Foster, S. A.
    Manjelievskaia, J.
    Ford, J. H.
    Ye, W.
    Perry, A.
    Schuh, K.
    Wenzel, R.
    HEADACHE, 2021, 61 : 54 - 54
  • [8] Switching associated with initiation of calcitonin gene-related peptide monoclonal antibodies versus non-calcitonin gene-related peptide monoclonal antibodies treatments for prevention of migraine
    Foster, S. A.
    Manjelievskaia, J.
    Ford, J. H.
    Ye, W.
    Perry, A.
    Schuh, K.
    Wenzel, R.
    HEADACHE, 2021, 61 : 75 - 76
  • [9] Monoclonal antibodies against calcitonin gene-related peptide for the prophylaxis of migraine with aura
    Kim, B. K.
    Lee, H. C.
    Cho, S.
    JOURNAL OF HEADACHE AND PAIN, 2024, 25
  • [10] The effect of calcitonin gene-related peptide monoclonal antibodies on restless legs syndrome in patients with migraine
    Suzuki, Keisuke
    Suzuki, Shiho
    Fujita, Hiroaki
    Kobayashi, Saro
    Shioda, Mukuto
    Hida, Ryotaro
    Hirata, Koichi
    JOURNAL OF HEADACHE AND PAIN, 2025, 26 (01):
12345